Your browser doesn't support javascript.
loading
Cost-Effectiveness Evaluation of Brentuximab Vedotin for Refractory/Relapsed Hodgkin Lymphoma: A Comparative Analysis of the Results of Mexico and Venezuela.
Meza-Torres, B; Gay, J G; Jakouloff, D E.
Affiliation
  • Meza-Torres B; Ti Salud, Mexico City, Mexico.
  • Gay JG; Ti Salud, Mexico City, Mexico.
  • Jakouloff DE; Takeda Pharmaceuticals, Zurich, Switzerland.
Value Health ; 17(7): A637, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27202272
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Country/Region as subject: America do sul / Mexico / Venezuela Language: En Journal: Value Health Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Country/Region as subject: America do sul / Mexico / Venezuela Language: En Journal: Value Health Year: 2014 Document type: Article